本文選題：醫(yī)藥代表　切入點：激勵制度　出處：《吉林大學》2013年碩士論文

【摘要】：據(jù)中國社會科學院發(fā)布的《醫(yī)藥藍皮書：中國藥品市場報告（2012）》介紹，2012年中國藥品市場規(guī)模達到9261億元。 藍皮書指出，中國藥品市場呈現(xiàn)出高速擴容、市場競爭激烈、行業(yè)集中度低的特點。新上市的原研藥越來越慢、越來越少，專利過期的原研藥和仿制藥占有了絕大部分的市場份額，逐漸呈現(xiàn)同質(zhì)化競爭，產(chǎn)品差異變小，醫(yī)藥企業(yè)之間的競爭更多的是依靠銷售團隊的競爭力，而醫(yī)藥代表就是組成銷售團隊的最基本單位。因此，適時適度地激勵醫(yī)藥代表，使他們對工作充滿熱情，從而提高整個銷售團隊的競爭力，是醫(yī)藥公司實現(xiàn)銷售目標的關鍵。 本文首先介紹了我國制藥企業(yè)和醫(yī)藥代表生存的大環(huán)境。行業(yè)景氣度下降，競爭激烈，從業(yè)人員收入減少，在這樣的背景下打造一支具有競爭力的銷售團隊既關鍵也困難。處于大環(huán)境中的BI公司面臨同樣的壓力，，急需一套完善的激勵制度來提高醫(yī)藥代表的積極性。筆者介紹了BI公司的概況和目前施行的醫(yī)藥代表激勵制度，指出了BI公司激勵制度在績效考核、薪酬激勵、職業(yè)發(fā)展三個方面存在的弊端并分析其成因，最后針對這些問題提出了具體的優(yōu)化方案�？冃Э己艘隕TMS（電子區(qū)域管理系統(tǒng)），將銷售過程通過KPI（關鍵績效指標）量化，以此做到考核的公平、公正、公開，做到重視結(jié)果又不忽視過程。薪酬制度既要能滿足醫(yī)藥代表的基本生活需要，還要體現(xiàn)出代表的個人價值，同時要兼顧公平性和靈活性。要為代表的職業(yè)發(fā)展創(chuàng)造機會，特別要關注到負責小市場代表的發(fā)展需要，提供平等的職業(yè)發(fā)展平臺，還要有針對性地對代表的各項技能進行培訓。BI公司作為一家大型跨國制藥公司，其產(chǎn)品覆蓋的領域廣，生產(chǎn)、銷售、管理都具有一般跨國企業(yè)的典型性，它在激勵制度方面的問題也是在華大型外企普遍為之困擾的問題。希望本文所做的分析和提出的優(yōu)化方案能為制藥企業(yè)以及其它以人員推銷為主的行業(yè)提供關于激勵制度建設方面的參考和借鑒。
[Abstract]:China's drug market reached 926.1 billion yuan in 2012, according to the Blue Book of Medicine: China's Drug Market report (2012), issued by the Chinese Academy of Social Sciences.The Blue Book points out that the Chinese drug market is characterized by rapid expansion, fierce market competition and low industry concentration.The newly listed raw research drugs are becoming more and more slow and fewer, the patent expired raw research drugs and generic drugs account for the vast majority of the market share, gradually showing homogenization competition, product differences become smaller.The competition among pharmaceutical enterprises depends more on the competitiveness of the sales team, and the pharmaceutical representative is the most basic unit of the sales team.Therefore, it is the key for pharmaceutical companies to encourage pharmaceutical representatives to be enthusiastic about their work and improve the competitiveness of the whole sales team.Firstly, this paper introduces the environment of pharmaceutical enterprises and pharmaceutical representatives in our country.A competitive sales team is critical and difficult to build against a backdrop of declining industry momentum, intense competition, and reduced income for employees.The BI Company is under the same pressure and needs a perfect incentive system to improve the enthusiasm of pharmaceutical representatives.This paper introduces the general situation of BI Company and the incentive system for pharmaceutical representatives, points out the disadvantages of the incentive system of BI Company in three aspects: performance appraisal, salary incentive and career development, and analyzes its causes.Finally, a specific optimization scheme is proposed to solve these problems.Performance appraisal is introduced into ETMS (Electronic area Management system), which quantifies the sales process through KPI (key performance Index), so that the evaluation is fair, fair, open and pays attention to the results without neglecting the process.The salary system can not only meet the basic needs of medical representatives, but also reflect the personal value of the representatives, and at the same time give consideration to fairness and flexibility.To create opportunities for the career development of delegates, paying particular attention to the development needs of representatives responsible for small markets and providing an equal career development platform,As a large multinational pharmaceutical company, as a large multinational pharmaceutical company, its products cover a wide range of fields, such as production, marketing and management, all of which are typical of general multinational enterprises.Its incentive system is also a common problem for large foreign companies in China.It is hoped that the analysis and optimization scheme can be used as a reference for pharmaceutical enterprises and other industries in which the promotion of personnel is the main factor in the construction of incentive system.
【學位授予單位】：吉林大學
【學位級別】：碩士
【學位授予年份】：2013
【分類號】：F426.72;F272.92

【參考文獻】

相關期刊論文 前7條

1 蔣寒迪;銷售人員的激勵扭曲與反饋激勵分析[J];財經(jīng)理論與實踐;2005年05期

2 張立;張德常;;銷售人員線性激勵合同的信息經(jīng)濟學分析[J];財經(jīng)理論與實踐;2006年02期

3 張傳明;王楊;;激勵設計中棘輪效應的分析[J];山東科技大學學報(自然科學版);2007年02期

4 沈榮;;醫(yī)藥企業(yè)對醫(yī)藥代表的激勵機制和約束機制研究[J];現(xiàn)代管理科學;2006年08期

5 徐敏;黃德華;冷駿峰;;醫(yī)藥代表的職業(yè)價值[J];醫(yī)藥導報;2008年03期

6 張明輝,陳光波;激勵理論與激勵方案設計[J];中國人力資源開發(fā);2001年01期

7 田效勛;考核出業(yè)績還是管理出業(yè)績[J];中國人力資源開發(fā);2002年12期

本文編號：1703237